In situ analysis of interleukin-6 expression at different sites of zygapophyseal joints from patients with ankylosing spondylitis in comparison to controls.

about

Evidence of response to IL-6 inhibition in some cases of refractory spondyloarthritis-associated peripheral synovitis.

P2860

Q52816898-E1C617C1-456A-4E0C-9A03-AF74452E9276

P2860

In situ analysis of interleukin-6 expression at different sites of zygapophyseal joints from patients with ankylosing spondylitis in comparison to controls.

Item

http://www.wikidata.org/entity/Q41269976

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

In situ analysis of interleuki ...... tis in comparison to controls.

@en

type

Item

label

In situ analysis of interleuki ...... tis in comparison to controls.

@en

prefLabel

In situ analysis of interleuki ...... tis in comparison to controls.

@en

P1476

In situ analysis of interleuki ...... tis in comparison to controls.

@en

P2093

H Appel

http://www.w3.org/2001/XMLSchema#string

J Bleil

http://www.w3.org/2001/XMLSchema#string

J Sieper

http://www.w3.org/2001/XMLSchema#string

R Maier

http://www.w3.org/2001/XMLSchema#string

U Syrbe

http://www.w3.org/2001/XMLSchema#string

P2860

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis

Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis.

Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial.

Analysis of IL-17(+) cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response

Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases.

The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria?

Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab

Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials

Pathogenesis of ankylosing spondylitis.

P304

296-301

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/03009742.2014.1000371

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25928402

http://www.w3.org/2001/XMLSchema#string

In situ analysis of interleukin-6 expression at different sites of zygapophyseal joints from patients with ankylosing spondylitis in comparison to controls.

about

P2860

P2860

In situ analysis of interleukin-6 expression at different sites of zygapophyseal joints from patients with ankylosing spondylitis in comparison to controls.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698